Showing results (111-120 of 322) with videos related to
Sort By:
Pageof 33
Scandinavian Journal of Infectious Diseases|January 1, 1992
A comparison of netilmicin and tobramycin therapy in patients with renal impairmentG J Gorse, J M Bernstein, R E Cronin, et al.Burns : Journal of the International Society for Burn Injuries|June 2, 2022
Surgical simulation training for escharotomy: A novel course, improving candidate's confidence in a time critical procedureJohn A G Gibson, Sarah Hemington Gorse, Ian Pallister, et al.Journal of the Air & Waste Management Association (1995)|January 7, 2017
Real-World Vehicle Emissions: A Summary of the Eighth Coordinating Research Council On-Road Vehicle Emissions WorkshopSteven H Cadle, Robert A Gorse, Timothy C Belian, et al.Journal of the Air & Waste Management Association (1995)|January 13, 2017
Real-World Vehicle Emissions: A Summary of the Seventh Coordinating Research Council On-Road Vehicle Emissions WorkshopSteven H Cadle, Robert A Gorse, Timothy C Belian, et al.The Journal of Hand Surgery, European Volume|April 25, 2024
Malignant melanoma in the hand: current evidence and recommendationsNatalie Blessley-Redgrave, Frances Bowerman, Hywel Dafydd, et al.Plos One|August 28, 2015
A Linear Mixed Model Spline Framework for Analysing Time Course 'Omics' DataJasmin Straube, Alain-Dominique Gorse, , et al.Clinical and Vaccine Immunology : CVI|October 15, 2010
Prevalence of antibodies to four human coronaviruses is lower in nasal secretions than in serumGeoffrey J Gorse, Gira B Patel, Joseph N Vitale, et al.Journal of the Air & Waste Management Association (1995)|February 19, 2000
Real-world vehicle emissions: a summary of the Ninth Coordinating Research Council On-Road Vehicle Emissions WorkshopS H Cadle, R A Gorse, B K Bailey, et al.Vaccine|December 13, 2003
Binding of antibodies to human immunodeficiency virus type 1 (HIV-1)-infected lymphocytes elicited by vaccines and by natural infectionGeoffrey J Gorse, Gira B Patel, J Alan Arbuckle, et al.Vaccine|January 1, 1992
Lymphocyte proliferative responses following immunization with human immunodeficiency virus recombinant GP160. The NIAID AIDS Vaccine Clinical Trials NetworkG J Gorse, R B Belshe, F K Newman, et al.Pageof 33